Cancer medicines
Cetuximab
Cetuximab
An EGFR-targeting antibody for selected colorectal and head and neck cancers.
Sources checked · Introductory guide
On this page
How it works
It binds EGFR to block cell growth signaling.[3]
Where it is used
Used in selected metastatic colorectal and head and neck squamous cancers. Colorectal use requires review of RAS and other molecular results and the combination regimen.[1]
Key safety points
Monitor infusion reactions, skin symptoms and electrolyte loss. Report breathlessness, swelling or faintness during infusion immediately.[2]
Questions for your care team
- How do my molecular results guide treatment, skin care and magnesium monitoring?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Cetuximab (opens in a new tab)
- MedlinePlus · Cetuximab (opens in a new tab)
- NCI Drug Dictionary · Cetuximab (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.